“Lots of content – makes you realize “you don’t know what you don’t know”.”

Carlene Variyan, , RBP Canada

“Well organized. Experienced speakers. Meeting interesting people.”

Dino Massimi, , Sivem Pharmaceutical

“Informative. Well known stakeholders provided valuable info and new learnings from a variety of perspectives.”

Laura Gibon, , PDCI Market Access Inc.

“Very comprehensive. A solid overview of the current state of market access in Canada and globally.”

Greg Buie, Brand Director, Novartis

“Great selection of topcs and speakers. Timing and presentation counts well planned. Food was up to par.”

Roman Z., , Health Economics and Pricing Association, Takeda Canada

“The market access summit is a superb networking opportunity and a strategic MA event.”

G. Giroux, Director, Market Access, Pendo Pharm

“The complexity of private payer markets. Interesting to hear different concepts – from physicians, lawyers, and advocacy. Great selection of speakers. Interesting to see a different perspective from Marc-Andre Gagnon.”

Farah Jivraj, Health Technology Assessment Strategy, Sanofi

“Very good. A few key takeaways. Excellent information regarding the private plan market.”

Joe Quinto, Business Unit Manager, Galderma

“Excellent speaker line up. Room was quite warm. Great networking opportunities. Latest key issues discussed and insights presented.”

Cara Lacey, Manager, Program and Client Services, Wyatt Health

“Learning’s: how the various stakeholders (CADTH, PMPRB, pharma and private payers) are adjusting their approaches and business models to align with changes in local health policies and international pricing development – application of risk management approach and generation of real world experience.”

Aileen Li, Manager, Health Economics and Reimbursement , JNJ


Shane Castle, Senior Product Manager, Telus Health

“Very well organized and very relevant.”

Alain Madgin, Manager, Public Relations, National

“Very good. Some great topics and new learning.”

Joe Quinto, Business Unit Manager, Galderma Canada Inc

“The focus is aligned with where the field and industry are heading. Very nice to see physicians and patients included.”

Craig Wakeford, Manager, Sanofi Canada

“Very informative and broad aspects of market access covered.”

Apoorva Kelkar, Market Access Associate, Wyatt Health Management

“Market access difficulties and challenges and ideas for change have been very interesting.”

James Bao, Program Manager, Adjuvantz

“Good variety of speakers bringing multiple perspectives.”

Jim Williamson, Manager, External Affairs, Takeda Canada

“Excellent conference to network with colleagues across the industry.”

Kristina Gentes, Manager, Reimbursement and Med. Affairs, Servier Canada Inc

“All sessions have been informative. I liked the variety in the topics. For me, therapeutic sessions were most helpful.”

Natalie B., , McKesson

“Very good overview of different market access perspectives.”

Jean Chretien, Director, Marketing, Hospira

“Excellent / relevant topics. Good breadth of material. Liked the varied formats (panel vs. speaker)”

H. Jibry, Pharmaceutical Portfolio Manager, Shoppers Drug Mart

“Very well organized, good speakers so far.”

Basim Mansour, Business Development Analyst, PPC

“Great! New speakers and different topics from recent conferences!”

Barbara Ouellet, , Patented Medicine Prices Review Board

“The conference was very well run with some speakers being truly captivating!”

Craig Wakeford, , Sanofi-Aventis

“A good crash course on the market access landscape. It has the impact of providing good networking connections but also a broad survey of the regulatory landscape.”

Aaron Levo, , Canadian Cancer Society

“Great condensed version of what is going on in the market and how we got here.”

Fei Fei Liu, , Eli Lilly

“So far the presentations have lived up to my expectations. Very appropriate and informative. Great networking opportunities.”

Virginie Giroux, Specialist, Health Economics, Schering-Plough Canada

“Great group of attendees, good networking opportunities. Speakers are fantastic and clear, concise – relevant info.”

Linda Prytula, Director, Trade Relations, Mint Pharmaceuticals

“Good overview of key issues from most stakeholders.”

Leza Muir, SVP, Claims Services, Pacific Blue Cross

“Very good state of the nation from CDR. Great private payer panel. Overall good to reconnect w/industry”

Mike Leo, Manager, Market Access, Lundbeck Canada

“Presentations are relevant and informative on the current industry trends. Plan on utilizing the FTP for review of presentations.”

Ashley Kent, Medication Access Specialist, Shoppers Drug Mart

“The private payer panel was excellent.”

Christian Marcoux, Program Manager, PAH, SDM specialty health network

“Varied topics – good and well known speakers”

Chantal Bourgault, Director, Market Access, Servier

“A new field that I am being exposed to, great learning experience.”

Raffi Merdkhanian, Sr. Manager, Medical Info. And Regulatory Affairs, Ordinance Holdings

“Informative – educational.”

James MacMillan, Sr. Manager, Amgen Australia

“Very interesting with actual/recent topics & issues discussed.”

Mondher Mtibaa, Pricing & Reimbursement Specialist, Schering-Plough Canada Inc

“Great networking opportunity. Relaxed place. Interesting topics and speakers.”

Roozbeth Ghiami, Product Director, Brogan Inc.

“Very informative – I was specifically interested in the private payer recognizing the challenges they are faced with.”

Richard Dobing, Manager, Business and Operations Analysis, Compass Admin Services Ltd.